FDA approved new cancer therapy and delivers patient access in just 44 days

In the United States, where the health system maintains a strong structural bias toward rapid access once the regulator approves a therapy, the 44-day outcome translates into virtually immediate insured access for more than 90 per cent of Americans through a mix of private and public coverage. …